ScripHorizon Therapeutics PLC is building out its commercial plans for the launch of teprotumumab for the rare autoimmune condition thyroid eye disease (TED) in early 2020. Teprotumumab is pending at the
ScripBiopharmaceutical executives behind Rempex Pharmaceuticals Inc. and Mpex Pharmaceuticals Inc. raised $33m in Series A venture capital to launch Qpex Biopharma , continuing their entrepreneurial l
ScripThe Scrip 100 examines the financial performance of all companies that sell more than $1m worth of prescription drugs or spend more than $1m on drug-related R&D. Confusingly, the universe of companies
ScripMercaptor Discoveries , a new drug discovery business founded by research scientists, is striving to get its first compound into clinical testing as a treatment for neurodegenerative disorders without